Keywords
How to Cite
Abstract
The importance of conducting comparisons between sedatives in an Intensive Care Unit (ICU) lies in the need to identify the most effective and safe sedative agent, aiming to enhance the comfort and safety of patients. This article is an integrative literature review, of a descriptive nature, relying on materials freely and fully available on Scielo and PubMed databases from 2020 to 2024. Six articles directly related to the theme and chosen methodology were selected. The objective of this study was to identify and compare the main sedation strategies in critically ill patients. The research question, according to the PICO strategy, was: in mechanically ventilated patients in the ICU, what is the comparative efficacy of different sedation strategies in reducing mechanical ventilation time and the occurrence of adverse events? It was concluded that ciprofol is comparable to propofol in terms of good tolerance and efficacy for sedation. Dexmedetomidine is more effective in reducing mechanical ventilation (MV) time compared to propofol. There are no significant disparities in adverse effects and mechanical ventilation time between remimazolam besylate and propofol. Propofol significantly reduced mechanical ventilation time compared to midazolam. Remimazolam besylate emerges as a potential substitute for propofol and midazolam, with a lower likelihood of causing hemodynamic depression and contamination compared to propofol. The combination of dexmedetomidine with propofol demonstrated the ability to reduce recovery and extubation periods in mechanically ventilated patients.
References
Andrade TR, Salluh JIF, Garcia R, Farah D, Silva PSLD, Bastos DF, Fonseca MCM. A cost-effectiveness analysis of propofol versus midazolam for the sedation of adult patients admitted to the intensive care unit. Revista Brasileira de Terapia Intensiva, v. 3, n. 33, p. 428-433, jul-sep, 2021. Doi: 10.5935/0103-507X.20210068.
Aitken LM, Bucknall T, Kent B, Mitchell M, Burmeister E, Keogh SJ. Protocol-directed sedation versus non-protocol-directed sedation to reduce duration of mechanical ventilation in mechanically ventilated intensive care patients. In: The Cochrane Collaboration editor. Cochrane Database of Systematic Reviews. Hoboken, NJ: John Wiley & Sons, Ltd (2015). Doi: 10.1002/14651858.CD009771.
Dou H, Hu F, Wang W, Ling L, Wang D, Liu F. Assessment of the sedative effects of dexmedetomidine and propofol treatment in patients undergoing mechanical ventilation in the ICU and relationship between treatment and occurrence of ventilator-associated pneumonia and detection of pathogenic bacteria. Experimental and Therapeutic Medicine, v. 1, n. 20, p. 599-606, 2020. Doi: 10.3892/etm.2020.8699.
Heybati K, Zhou F, Ali S, Deng J, Mohananey D, Villablanca P, Ramakrishna H. Outcomes of dexmedetomidine versus propofol sedation in critically ill adults requiring mechanical ventilation: a systematic review and meta-analysis of randomised controlled trials. The British Journal of Anaesthesia, v. 4, n. 129, p. 515-526, oct, 2022 Doi: 10.1016/j.bja.2022.06.020.
Liu Y, Yu X, Zhu D, Zeng J, Lin Q, Zang B, Chen C, Liu N, Liu X, Gao W, Guan X. Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mechanical ventilation: a multi-center, open label, randomized, phase 2 trial. Chinese Medical Journal, v. 9, n. 135, p. 1043-1051, may, 2022. Doi: 10.1097/CM9.0000000000001912.
Qiu Y, Gu W, Zhao M, Zhang Y, Wu J. The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: A randomized trial. Frontiers in Medicine, Aug., 8;9:938940, 2022. Doi: 10.3389/fmed.2022.938940.
Page V, McKenzie C. Sedation in the Intensive Care Unit. Current Anesthesiology Reports, v. 2, n. 11, p. 92-100, 2021. Doi: 10.1007/s40140-021-00446-5.
Tang Y, Yang X, Yu Y, Shu H, Xu J, Li R, Zou X, Yuan S, Shang Y. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes. Minerva Anestesiologica, v. 11, n. 88, p. 939-949, nov., 2022. Doi: 10.23736/S0375-9393.22.16631-9. Epub 2022 Jul 5. PMID: 35785930.
Walsh TS, Kydonaki K, Antonelli J, Stephen J, Lee RJ, Everingham K, et al. Staff education, regular sedation and analgesia quality feedback, and a sedation monitoring technology for improving sedation and analgesia quality for critically ill, mechanically ventilated patients: a cluster randomised trial. The Lancet Respiratory Medicine, 4:807–17, 2016. Doi: 10.1016/S2213-2600(16)30178-3.
Yang X, Tang Y, Du R, Yu Y, Xu J, Zhang J, Liu H, Zou X, Ren L, Yuan S, Shang Y. Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial. Frontiers in Pharmacology, 28, jul., 2023. Doi: 10.3389/fphar.2023.1139872.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Alana Kundsin , Alex Blank de Paula , Larissa Claro Spiguel , Renan Sesquim Cardoso